Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

104
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
104
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Synergistic Regulation of Lung Cancer Cell Migration by Tensile Stress and Matrix Stiffness.

Cellular and molecular bioengineering·2026
Same author

Progress in immunotherapy for <i>Helicobacter pylori</i> infections.

Frontiers in cellular and infection microbiology·2026
Same author

Cysteine Supplementation During In Vitro Maturation Enhances Bovine Oocyte Developmental Competence Through Improved Redox Balance and Mitochondrial Function.

Biology·2026
Same author

Gradient-Driven Galvanic Effect Enables Self-Sustained Peroxymonosulfate Activation in a Stacked Flow Reactor.

Environmental science & technology·2026
Same author

<i>T</i> Gene Mutation Leads to Short Tail in Sheep via Premature AER Degeneration: Single-Cell Evidence from Embryos.

Animals : an open access journal from MDPI·2026
Same author

Wearable Sleep Detection System Based on Piezoelectric Signals and Convolutional Neural Network Analysis.

Langmuir : the ACS journal of surfaces and colloids·2026

Related Experiment Video

Updated: Jun 11, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.0K

Machine learning-based individualized survival prediction model for prognosis in osteosarcoma: Data from the SEER

Ping Cao1, Yixin Dun2, Xi Xiang1

  • 1Department of Orthopedic, The Frist Affiliated Hospital of Dalian Medical University, Dalian, China.

Medicine
|September 27, 2024
PubMed
Summary

Machine learning models, particularly DeepSurv, show superior accuracy in predicting osteosarcoma patient survival compared to traditional methods. These AI tools can guide personalized treatment decisions for better patient outcomes.

More Related Videos

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

742
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.8K

Related Experiment Videos

Last Updated: Jun 11, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.0K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

742
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.8K

Area of Science:

  • Oncology
  • Biostatistics
  • Machine Learning in Medicine

Background:

  • Osteosarcoma patient outcomes are variable due to tumor heterogeneity and diverse treatment approaches.
  • Accurate prognosis prediction is crucial for effective clinical decision-making in osteosarcoma management.

Purpose of the Study:

  • To compare the predictive performance of machine learning (ML) models against the Cox proportional hazards (CoxPH) model for osteosarcoma survival.
  • To explore the utility of ML models in facilitating personalized treatment recommendations for osteosarcoma patients.

Main Methods:

  • Utilized data from 1243 osteosarcoma patients (2000-2018) from the SEER database.
  • Developed and validated DeepSurv, NMTLR, and RSF ML models against the CoxPH model and TNM staging.
  • Assessed model performance using concordance index (C-index), Integrated Brier Score (IBS), ROC curves, AUC, calibration, and decision curve analysis.

Main Results:

  • The DeepSurv model demonstrated the highest performance (C-index: 0.77, 3-year AUC: 0.80, 5-year AUC: 0.78), outperforming other ML models and CoxPH.
  • DeepSurv model-recommended treatment alignments showed significantly better survival outcomes (HR: 1.88, P < .05).
  • A web application for the DeepSurv model is publicly accessible for clinical use.

Conclusions:

  • Machine learning models, especially DeepSurv, offer enhanced accuracy in predicting osteosarcoma survival.
  • These ML models can provide valuable insights for optimizing clinical decision-making and personalized treatment strategies.
  • The developed DeepSurv model and its web app offer a practical tool for improving osteosarcoma patient care.